Use of data from registered clinical trials to identify gaps in health research and development
OBJECTIVE: To explore what can be learnt about the current composition of the "global landscape" of health research and development (R & D) from data on the World Health Organization's International Clinical Trials Registry Platform (ICTRP). METHODS: A random 5% sample of the reco...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The World Health Organization
|
| Series: | Bulletin of the World Health Organization |
| Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000600009&lng=en&tlng=en |
| _version_ | 1797288183625416704 |
|---|---|
| author | Roderik F Viergever Robert F Terry Ghassan Karam |
| author_facet | Roderik F Viergever Robert F Terry Ghassan Karam |
| author_sort | Roderik F Viergever |
| collection | DOAJ |
| description | OBJECTIVE: To explore what can be learnt about the current composition of the "global landscape" of health research and development (R & D) from data on the World Health Organization's International Clinical Trials Registry Platform (ICTRP). METHODS: A random 5% sample of the records of clinical trials that were registered as interventional and actively recruiting was taken from the ICTRP database. FINDINGS: Overall, 2381 records of trials were investigated. Analysis of these records indicated that, for every million disability-adjusted life years (DALYs) caused by communicable, maternal, perinatal and nutritional conditions, by noncommunicable diseases, or by injuries, the ICTRP database contained an estimated 7.4, 52.4 and 6.0 trials in which these causes of burden of disease were being investigated, respectively. For every million DALYs in high-income, upper-middle-income, lower-middle-income and low-income countries, an estimated 292.7, 13.4, 3.0 and 0.8 registered trials, respectively, were recruiting in such countries. CONCLUSION: The ICTRP constitutes a valuable resource for assessing the global distribution of clinical trials and for informing policy development for health R & D. Populations in lower-income countries receive much less attention, in terms of clinical trial research, than populations in higher-income countries. |
| first_indexed | 2024-03-07T18:45:37Z |
| format | Article |
| id | doaj.art-a82bae4af77c4efb875b2da0409f94c0 |
| institution | Directory Open Access Journal |
| issn | 0042-9686 |
| language | English |
| last_indexed | 2024-03-07T18:45:37Z |
| publisher | The World Health Organization |
| record_format | Article |
| series | Bulletin of the World Health Organization |
| spelling | doaj.art-a82bae4af77c4efb875b2da0409f94c02024-03-02T02:41:09ZengThe World Health OrganizationBulletin of the World Health Organization0042-9686916416425C10.2471/BLT.12.114454S0042-96862013000600009Use of data from registered clinical trials to identify gaps in health research and developmentRoderik F Viergever0Robert F TerryGhassan Karam1Radboud UniversityRadboud UniversityOBJECTIVE: To explore what can be learnt about the current composition of the "global landscape" of health research and development (R & D) from data on the World Health Organization's International Clinical Trials Registry Platform (ICTRP). METHODS: A random 5% sample of the records of clinical trials that were registered as interventional and actively recruiting was taken from the ICTRP database. FINDINGS: Overall, 2381 records of trials were investigated. Analysis of these records indicated that, for every million disability-adjusted life years (DALYs) caused by communicable, maternal, perinatal and nutritional conditions, by noncommunicable diseases, or by injuries, the ICTRP database contained an estimated 7.4, 52.4 and 6.0 trials in which these causes of burden of disease were being investigated, respectively. For every million DALYs in high-income, upper-middle-income, lower-middle-income and low-income countries, an estimated 292.7, 13.4, 3.0 and 0.8 registered trials, respectively, were recruiting in such countries. CONCLUSION: The ICTRP constitutes a valuable resource for assessing the global distribution of clinical trials and for informing policy development for health R & D. Populations in lower-income countries receive much less attention, in terms of clinical trial research, than populations in higher-income countries.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000600009&lng=en&tlng=en |
| spellingShingle | Roderik F Viergever Robert F Terry Ghassan Karam Use of data from registered clinical trials to identify gaps in health research and development Bulletin of the World Health Organization |
| title | Use of data from registered clinical trials to identify gaps in health research and development |
| title_full | Use of data from registered clinical trials to identify gaps in health research and development |
| title_fullStr | Use of data from registered clinical trials to identify gaps in health research and development |
| title_full_unstemmed | Use of data from registered clinical trials to identify gaps in health research and development |
| title_short | Use of data from registered clinical trials to identify gaps in health research and development |
| title_sort | use of data from registered clinical trials to identify gaps in health research and development |
| url | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000600009&lng=en&tlng=en |
| work_keys_str_mv | AT roderikfviergever useofdatafromregisteredclinicaltrialstoidentifygapsinhealthresearchanddevelopment AT robertfterry useofdatafromregisteredclinicaltrialstoidentifygapsinhealthresearchanddevelopment AT ghassankaram useofdatafromregisteredclinicaltrialstoidentifygapsinhealthresearchanddevelopment |